169 related articles for article (PubMed ID: 29980757)
1. Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.
Henderson JM; Polak N; Chen J; Roediger B; Weninger W; Kench JG; McCaughan GW; Zhang HE; Gorrell MD
Sci Rep; 2018 Jul; 8(1):10283. PubMed ID: 29980757
[TBL] [Abstract][Full Text] [Related]
2. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
[TBL] [Abstract][Full Text] [Related]
3. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
4. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential targets with high centrality indicated by diethylnitrosamine + thioacetamide-induced hepatocellular carcinoma model.
Hora S; Asad M; Jain SK; Katare DP
J Cancer Res Ther; 2021; 17(4):1081-1092. PubMed ID: 34528568
[TBL] [Abstract][Full Text] [Related]
6. Diethylnitrosamine enhances hepatic tumorigenic pathways in mice fed with high fat diet (Hfd).
Arboatti AS; Lambertucci F; Sedlmeier MG; Pisani G; Monti J; Álvarez ML; Francés DEA; Ronco MT; Carnovale CE
Chem Biol Interact; 2019 Apr; 303():70-78. PubMed ID: 30826251
[TBL] [Abstract][Full Text] [Related]
7. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
8. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
[TBL] [Abstract][Full Text] [Related]
9. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
11. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
[TBL] [Abstract][Full Text] [Related]
13. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T; Pogribny IP; Rusyn I
Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
[TBL] [Abstract][Full Text] [Related]
14. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Memon A; Pyao Y; Jung Y; Lee JI; Lee WK
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751728
[TBL] [Abstract][Full Text] [Related]
15. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.
Fujii M; Shibazaki Y; Wakamatsu K; Honda Y; Kawauchi Y; Suzuki K; Arumugam S; Watanabe K; Ichida T; Asakura H; Yoneyama H
Med Mol Morphol; 2013 Sep; 46(3):141-52. PubMed ID: 23430399
[TBL] [Abstract][Full Text] [Related]
16. Dietary Choline Supplementation Attenuates High-Fat-Diet-Induced Hepatocellular Carcinoma in Mice.
Brown AL; Conrad K; Allende DS; Gromovsky AD; Zhang R; Neumann CK; Owens AP; Tranter M; Helsley RN
J Nutr; 2020 Apr; 150(4):775-783. PubMed ID: 31851339
[TBL] [Abstract][Full Text] [Related]
17. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio.
Rekha RD; Amali AA; Her GM; Yeh YH; Gong HY; Hu SY; Lin GH; Wu JL
Toxicology; 2008 Jan; 243(1-2):11-22. PubMed ID: 17997003
[TBL] [Abstract][Full Text] [Related]
18. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E.
Coia H; Ma N; Hou Y; Dyba MD; Fu Y; Cruz MI; Benitez C; Graham GT; McCutcheon JN; Zheng YL; Sun B; Kallakury BV; Ma J; Fang HB; Berry DL; Muralidaran V; Chung FL
Cancer Prev Res (Phila); 2018 Oct; 11(10):665-676. PubMed ID: 30131435
[TBL] [Abstract][Full Text] [Related]
20. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
